These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 383854)

  • 1. Susceptibility of Escherichia coli K1 to four combinations of antimicrobial agents potentially useful for treatment of neonatal meningitis.
    Paisley JW; Washington JA
    J Infect Dis; 1979 Aug; 140(2):183-91. PubMed ID: 383854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.
    Kim KS; Manocchio M; Anthony BF
    Antimicrob Agents Chemother; 1984 Nov; 26(5):689-93. PubMed ID: 6393867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal meningitis: is the combination ampicillin-gentamycin obsolete?].
    Muytjens HL; Kollée LA
    Tijdschr Kindergeneeskd; 1985 Oct; 53(5):185-8. PubMed ID: 3911489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gentamicin and kanamycin alone and in combination with ampicillin in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Pediatr Res; 1985 Nov; 19(11):1152-5. PubMed ID: 3906546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsing E. coli K1 antigen meningitis in a newborn.
    Helms PJ
    Arch Dis Child; 1977 Feb; 52(2):152-4. PubMed ID: 319766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of cefamandole in neonatal purulent meningitis caused by E. coli (author's transl)].
    Yamamoto T; Hirata S; Yokoi Y; Ohtani T; Hosoe A; Nishimura Y
    Jpn J Antibiot; 1981 Oct; 34(10):1410-5. PubMed ID: 7038185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
    Lehtolainen T; Shwimmer A; Shpigel NY; Honkanen-Buzalski T; Pyörälä S
    J Dairy Sci; 2003 Dec; 86(12):3927-32. PubMed ID: 14740828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
    Beam TR; Allen JC
    Antimicrob Agents Chemother; 1980 Jan; 17(1):37-42. PubMed ID: 6986115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningitis due to two serotypes of Escherichia coli. An infant who recovered.
    Goldenberg RI; Neter E
    Am J Dis Child; 1977 Feb; 131(2):213-4. PubMed ID: 319655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of 126 isolates of Escherichia coli from the cerebrospinal fluid of neonates to five antibiotics.
    Mulder CJ; Bol P; Nabbe AJ; Zanen HC
    J Antimicrob Chemother; 1985 Jan; 15(1):115-8. PubMed ID: 3882652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis.
    McCracken GH
    Am J Dis Child; 1972 Jun; 123(6):547-53. PubMed ID: 4555935
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Gratz JC; Foresman P; Rodeheaver G
    Antimicrob Agents Chemother; 1983 Nov; 24(5):682-8. PubMed ID: 6362552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing pattern of the antimicrobial susceptibilities of Escherichia coli in neonatal infections.
    McCracken GH
    J Pediatr; 1971 Jun; 78(6):942-7. PubMed ID: 4325223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bactericidal activity of ampicillin, chloramphenicol and gentamicin, alone or in combinations against susceptible and resistant "Haemophilus influenzae" (author's transl)].
    Dabernat HJ; Delmas C; Bauriaud R; Lareng MB
    Ann Microbiol (Paris); 1979; 130 A(4):469-79. PubMed ID: 315746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones.
    Kronvall G; Larsson M; Borén C; Kahlmeter G; Bartoloni A; Rossolini GM; Grape M; Kristiansson C; Karlsson I
    Int J Antimicrob Agents; 2005 Dec; 26(6):473-8. PubMed ID: 16280241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivities of strains of enteropathogenic Escherichia coli to cephalexin and other antibiotics.
    Konforti N; Halperin E
    Am J Clin Pathol; 1975 Jul; 64(1):121-6. PubMed ID: 1098437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.